Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain
Authors:
- Michel GillardMichel Gillard
- Bruno FuksBFBruno Fuks
- Philippe MichelPMPhilippe Michel
- Roy MassinghamRMRoy Massingham
- Pierre ChatelainPCPierre Chatelain
- 1 September 2003
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 478 (1) , 1-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell linesEuropean Journal of Pharmacology, 2003
- Levetiracetam: A Novel Antiepileptic DrugPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?Epilepsia, 2001
- Evaluation of native GABAA receptors containing an α5 subunitEuropean Journal of Pharmacology, 2001
- Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsyEuropean Journal of Pharmacology, 1998
- Characterization of the binding of [3H]‐SB‐204269, a radiolabelled form of the new anticonvulsant SB‐204269, to a novel binding site in rat brain membranesBritish Journal of Pharmacology, 1997
- Furosemide interactions with brain GABAA receptorsBritish Journal of Pharmacology, 1997
- The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium ChannelJournal of Biological Chemistry, 1996
- Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studiesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973